ClearPoint Neuro, Inc. (CLPT)
| Previous close | 9.40 |
| Open | 9.41 |
| Bid | 9.29 x 2900 |
| Ask | 10.50 x 800 |
| Day's range | 9.34 - 10.07 |
| 52-week range | 7.00 - 16.96 |
| Volume | |
| Avg. volume | 77,588 |
| Market cap | 243.336M |
| Beta (5Y monthly) | 1.09 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.72 |
| Earnings date | 27 Feb 2023 - 03 Mar 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 22.00 |
- GlobeNewswire
ClearPoint Neuro Reports Fourth Quarter and Full Year 2022 Preliminary Revenue Results and Guidance for Full Year 2023 Revenue
SOLANA BEACH, Calif., Jan. 11, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced preliminary, unaudited financial results for its fourth quarter and full year ended December 31, 2022. Fourth Quarter 2022 Preliminary Unaudited Financial Highlights Preliminary unaudited revenue of $5.2 million, a 21% year-over-year increase;Increased biologics and drug delivery r
- GlobeNewswire
ClearPoint Neuro Announces First Patient Enrolled in Glioblastoma Trial Using ClearPoint Prism™ Neuro Laser Therapy System at Skåne University Hospital in Sweden
The ClearPoint Prism™ Neuro Laser Therapy System The ClearPoint Prism™ Neuro Laser Therapy System SOLANA BEACH, Calif., Dec. 12, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced enrollment of the first patient in a Glioblastoma clinical trial using the ClearPoint Prism™ Neuro Laser Therapy System at Skåne University Hospital in Lund, Sweden (SUS Lund). The Saf
- GlobeNewswire
ClearPoint Neuro to Present at Upcoming Investor Conferences
SOLANA BEACH, Calif., Nov. 09, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, announced today that its management will present at the following investor conferences: 2022 Stifel Healthcare ConferencePresenting on Tuesday, November 15, 2022 at 10:55 a.m. Eastern Time in New York, NY. 34th Annual Piper Sandler Healthcare ConferencePresenting on Tuesday, November 29, 2022 at 1
